PLSE(Pulse Biosciences, Inc.) · 财务报表

PLSE(Pulse Biosciences, Inc.) 的财务报表:医疗保健,医疗仪器与耗材。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$1.42M$700.00K$0$0$350.00K
毛利润−$550.00K−$11.24M$0$0−$189.00K
营业利润−$63.01M−$58.06M−$43.57M−$56.26M−$76.94M
净利润−$63.66M−$58.51M−$42.21M−$53.59M−$72.78M
经营现金流−$54.10M−$47.01M−$33.04M−$36.34M−$54.12M
自由现金流−$54.53M−$47.41M−$33.16M−$36.47M−$54.44M
摊薄每股收益$-2.28————

Pulse Biosciences, Inc. PLSE